Morgan Stanley
ENTXW

Morgan Stanley’s Entera Bio Ltd. Warrant ENTXW Stock Holding History

Morgan Stanley’s Portfolio ENTXW Stock Details ENTXW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-400
Closed – – 8016
2022
Q3 		$0 Hold
400
– – ﹤0.01% 8024
2022
Q2 		$0 Hold
400
– – ﹤0.01% 8126
2022
Q1 		$0 Hold
400
– – ﹤0.01% 8242
2021
Q4 		$0 Hold
400
– – ﹤0.01% 8228
2021
Q3 		$0 Hold
400
– – ﹤0.01% 8097
2021
Q2 		$0 Hold
400
– – ﹤0.01% 7847
2021
Q1 		$0 Hold
400
– – ﹤0.01% 7608
2020
Q4 		$0 Hold
400
– – ﹤0.01% 7163
2020
Q3 		$0 Buy
+400
New +$123 ﹤0.01% 6876

Other funds holding ENTXW

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley's ENTXW Position: Q4 2022 in Review

Morgan Stanley sold out of Entera Bio Ltd. Warrant (ENTXW) in Q4 2022, closing a stake of 400 shares.

Morgan Stanley first reported a position in ENTXW in Q3 2020 and held it in 9 quarters. The position peaked at $0 in Q3 2022. 1 fund tracked by Wall St. Rank holds ENTXW as of Q4 2022.

  • Morgan Stanley reported no remaining Entera Bio Ltd. Warrant position as of Q4 2022 after selling out during the quarter.
  • Morgan Stanley sold 400 Entera Bio Ltd. Warrant shares in Q4 2022.
  • Morgan Stanley first reported a position in Entera Bio Ltd. Warrant in Q3 2020 and held it in 9 quarters.
  • Morgan Stanley's Entera Bio Ltd. Warrant position peaked at $0 in Q3 2022.
  • 1 fund tracked by Wall St. Rank held Entera Bio Ltd. Warrant as of Q4 2022.

Based on Morgan Stanley's 13F filing for Q4 2022, filed 14 Feb 2023.